Murray Hill – Managing Director & CEO – Elevate Uranium (ASX:EL8) is a uranium exploration company that has significant resources in Namibia and Australia and is making new discoveries through active exploration programs.
Copyright 2024 – Finance News Network
Source: Finance News Network
31 Aug 2021 - VRX Silica Limited (ASX:VRX) Managing Director Bruce Maluish provides an update on the company's Arrowsmith and Muchea silica sand projects, potential offtake partners and financing.
Read More01 Apr 2022 - Lepidico Limited (ASX:LPD) Managing Director Joe Walsh discusses the progress of the company's Karibib lithium operations and Abu Dhabi processing plant, potential capital raisings and offtake agreements.
Read More20 Jan 2021 - National Retail Association CEO Dominique Lamb discusses retail performance over the Christmas period, trends in retail, and strategies for encouraging consumer spending.
Read More08 Jan 2020 - SUDA Pharmaceuticals Limited (ASX:SUD) CEO, Dr Michael Baker, talks about the company’s plans to develop Anagrelide, for the treatment of cancer, and to commercialise its lead product ZolpiMist worldwide.
Read More26 Mar 2020 - Lithium Consolidated Mineral Exploration Limited (ASX:LI3) Managing Director Andrew Haythorpe provides an update on the company's new WA projects prospective for gold, nickel and base metals, board changes and plans to improve the company’s prospects.
Read More10 Mar 2020 - Prospect Resources Limited (ASX:PSC) Managing Director, Sam Hosack, provides an update on the company's key lithium petalite project in Zimbabwe.
Read More10 Jul 2024 - The Honourable Shane Jones discusses the New Zealand government's pro-mining strategy. Topics touched on include: the rationale behind invigorating the resources sector, statutory reforms to boost investment, and commodities New Zealand possesses.
Read More16 Aug 2023 - Steven Yatomi Clarke - CEO and Managing Director - Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
Read More25 Oct 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses efficacy results for the company's glioblastoma therapy.
Read More19 Nov 2019 - Redcape Hotel Group Limited (ASX:RDC) CEO, Dan Brady discusses FY19 results, company strategy and creating pub venues that become the hub of local communities.
Read More
